Trial record 1 of 1 for:    INCB 18424-261
Previous Study | Return to List | Next Study

Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Incyte Corporation
ClinicalTrials.gov Identifier:
NCT01445769
First received: September 23, 2011
Last updated: March 3, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)